Karachaliou, Marianna http://orcid.org/0000-0002-3014-0747
Moncunill, Gemma
Espinosa, Ana
Castaño-Vinyals, Gemma
Rubio, Rocío
Vidal, Marta
Jiménez, Alfons
Prados, Esther
Carreras, Anna
Cortés, Beatriz
Blay, Natàlia
Bañuls, Marc
Pleguezuelos, Vanessa
Melero, Natalia Rodrigo
Serra, Pau
Parras, Daniel
Izquierdo, Luis
Santamaría, Pere
Carolis, Carlo
Papantoniou, Kyriaki
Goldberg, Ximena
Aguilar, Ruth
Garcia-Aymerich, Judith
de Cid, Rafael
Kogevinas, Manolis
Dobaño, Carlota
Funding for this research was provided by:
Incentius a l’Avaluació de Centres CERCA
EIT HEALTH (BP2020-20873-Certify.Health)
Fundació Privada Daniel Bravo Andreu (PID2019-110810RB-I00)
Institut Català de la Salut (PERIS SLT017/20/000224)
Junta de Andalucía/EU.
Spanish Ministry of Science and Innovation (CEX2018-000806-S)
Acción de Dinamización del ISCIII
Article History
Received: 8 April 2022
Accepted: 1 September 2022
First Online: 16 September 2022
Declarations
:
: All participants contacted had consented in the past to be re-contacted and had provided informed consent. Ethical approval was obtained from the Parc de Salut Mar Ethics Committee (CEIM-PS MAR, no. 2020/9307/I) and Hospital Universitari Germans Trias i Pujol Ethics Committee (CEI no. PI-20-182).
: Not applicable.
: P. Santamaria is the scientific founder of Parvus Therapeutics and has a financial interest in the company. The other authors declare that they have no competing interests.